Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Melissa Delgado

Obstetrics & Gynecology Vienna, VA Medical Doctor

NPI 1588760128 CMS profile 71463

8100 Boone Blvd Ste 710, Vienna, VA 22182

Open in the dashboard

General payments

$95,226

177 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$20,664 paid to institutions, not to them · program years 2023–2025

Through program year 2023, Melissa Delgado of Vienna, VA is reported in the CMS Open Payments database as having received $95,226 across 177 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $20,664 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $42 2
2022 General $3,438 7
2021 General $13,540 20
2020 General $12,378 24
2019 General $65,828 124

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Melissa Delgado
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Melissa Delgado were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Melissa Delgado Obstetrics & Gynecology median Middle half National median
2019 $65,828 $172 $62–$391 $163
2020 $12,378 $94 $36–$222 $114
2021 $13,540 $136 $42–$369 $132
2022 $3,438 $160 $50–$433 $149
2023 $42 $169 $56–$423 $160
2024 $0 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $91,556 157 payments
  2. Ironwood Pharmaceuticals, Inc $3,359 3 payments
  3. Myovant Sciences Inc. $81 4 payments
  4. AMAG Pharmaceuticals, Inc. $71 4 payments
  5. Abbott Laboratories $40 1 payment
  6. Mission Pharmacal Company $40 3 payments
  7. Exeltis, USA Inc. $25 1 payment
  8. ASCEND Therapeutics US, LLC $24 2 payments
  9. CooperSurgical, Inc. $16 1 payment
  10. Avion Pharmaceuticals $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $69,675 45 payments
  2. Travel and Lodging $12,744 45 payments
  3. Consulting Fee $9,590 3 payments
  4. Food and Beverage $3,109 77 payments
  5. Education $108 7 payments
Products named General payments · program years 2019–2023
  1. Orilissa Endocrinology $65,317 109 payments
  2. ORILISSA Womens Health $16,607 28 payments
  3. ORIAHNN $2,862 14 payments
  4. MYFEMBREE $81 4 payments
  5. INTRAROSA $52 3 payments
  6. Proclaim Family of SCS IPGs $40 1 payment
  7. Uribel $40 3 payments
  8. VYLEESI $37 2 payments
  9. SLYND $25 1 payment
  10. LO LOESTRIN FE $18 1 payment
  11. Other $55 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

177 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record